Tanaka E - Search Results

1

The effects of diltiazem on hepatic drug metabolizing enzymes in man using antipyrine, trimethadione and debrisoquine as model substrates.

Sakai H, Kobayashi S, Hamada K, Iida S, Akita H, Tanaka E, Uchida E, Yasuhara H. Sakai H, et al. Among authors: tanaka e. Br J Clin Pharmacol. 1991 Mar;31(3):353-5. doi: 10.1111/j.1365-2125.1991.tb05543.x. Br J Clin Pharmacol. 1991. PMID: 2054276 Free PMC article.

2

Trimethadione metabolism as a probe drug to estimate hepatic oxidizing capacity in rats.

Tanaka E, Ishikawa A, Kobayashi S, Yasuhara H, Misawa S, Kuroiwa Y. Tanaka E, et al. Comp Biochem Physiol C Comp Pharmacol Toxicol. 1993 Feb;104(2):205-7. doi: 10.1016/0742-8413(93)90025-g. Comp Biochem Physiol C Comp Pharmacol Toxicol. 1993. PMID: 8098675 Review.

3

Strain differences of antipyrine, trimethadione, and debrisoquine metabolism in female rats.

Tanaka E, Kobayashi S, Yasuhara H, Misawa S. Tanaka E, et al. Res Commun Chem Pathol Pharmacol. 1990 Aug;69(2):233-6. Res Commun Chem Pathol Pharmacol. 1990. PMID: 2396050 No abstract available.

4

Antipyrine metabolism in female Lewis and Dark Agouti strains of rats, which are extensive and poor metabolizers of debrisoquine, respectively.

Tanaka E, Kobayashi S, Uchida E, Oguchi K, Yasuhara H. Tanaka E, et al. Jpn J Pharmacol. 1989 Mar;49(3):433-5. doi: 10.1254/jjp.49.433. Jpn J Pharmacol. 1989. PMID: 2747044 Free article.

5

The effects of malotilate on hepatic drug metabolizing systems in different strains of rats.

Kai K, Kobayashi S, Uchida E, Sakai H, Tanaka E, Kurata N, Yasuhara H. Kai K, et al. Among authors: tanaka e. Comp Biochem Physiol C Comp Pharmacol Toxicol. 1988;90(1):13-9. Comp Biochem Physiol C Comp Pharmacol Toxicol. 1988. PMID: 2904852

6

Trimethadione as a probe drug to estimate hepatic oxidizing capacity in humans.

Tanaka E, Ishikawa A, Abei M, Kobayashi S. Tanaka E, et al. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1996 Nov;115(3):211-6. doi: 10.1016/s0742-8413(96)00102-8. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1996. PMID: 9375358 Review.

7

Simplified approach for determination of hepatic drug-oxidizing capacity using trimethadione metabolism as an indicator.

Tanaka E, Kobayashi S, Nakamura K, Uchida E, Yasuhara H. Tanaka E, et al. Biopharm Drug Dispos. 1989 Nov-Dec;10(6):617-20. doi: 10.1002/bdd.2510100611. Biopharm Drug Dispos. 1989. PMID: 2611361 Clinical Trial. No abstract available.

8

The effects of short-term administration of ibuprofen on trimethadione metabolism and antipyrine metabolite formation in the rat.

Tanaka E, Kobayashi S, Oguchi K, Kuroiwa Y, Yasuhara H. Tanaka E, et al. Res Commun Chem Pathol Pharmacol. 1985 May;48(2):317-20. Res Commun Chem Pathol Pharmacol. 1985. PMID: 4023417

9

The effect of indomethacin on hepatic drug-oxidizing capacity in the rat: trimethadione and antipyrine metabolism as an indicator.

Tanaka E, Kobayashi S, Aramphongphan A, Kurata N, Oguchi K, Kuroiwa Y, Yasuhara H. Tanaka E, et al. J Pharmacobiodyn. 1985 Sep;8(9):773-9. doi: 10.1248/bpb1978.8.773. J Pharmacobiodyn. 1985. PMID: 4087137

10

A method for estimation of hepatic drug-metabolizing capacity: determination of concentration of trimethadione and its metabolite in human serum.

Kobayashi S, Tanaka E, Oguchi K, Yoshida T, Kuroiwa Y, Yasuhara H. Kobayashi S, et al. Among authors: tanaka e. J Pharmacobiodyn. 1984 May;7(5):329-35. doi: 10.1248/bpb1978.7.329. J Pharmacobiodyn. 1984. PMID: 6470930

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,380 results

Search Page

Filters